Rigel Pharmaceuticals, Inc. (RIGL)

47.24 -0.04 (-0.08%) USD  |  NASDAQ  |  Sep 11, 16:00
47.26 +0.02 (+0.04%) Pre-Market: 20:00
More

Rigel Pharmaceuticals Price : 47.24 for Sept. 11, 2026

Price Chart

View Price for RIGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Chart
Start Trial

Historical Price Data

View and export this data back to 2000. Start Trial.
Date Open High Low Close Volume
Sep 11, 2026 47.84 47.86 47.00 47.24 187183.0
Sep 10, 2026 46.69 47.35 46.28 47.28 131329.0
Sep 09, 2026 46.85 47.88 46.78 47.22 177149.0
Sep 08, 2026 48.09 48.11 46.61 47.37 248396.0
Sep 04, 2026 48.04 48.87 47.77 48.67 104968.0
Sep 03, 2026 49.51 49.90 48.09 48.50 190390.0
Sep 02, 2026 48.00 49.70 47.73 49.42 184700.0
Sep 01, 2026 46.15 47.85 46.15 47.50 205505.0
Aug 31, 2026 46.04 46.59 45.31 46.18 243090.0
Aug 28, 2026 46.46 46.79 45.68 46.48 246125.0
Aug 27, 2026 46.29 47.00 45.60 46.86 210028.0
Aug 26, 2026 46.34 47.09 45.36 46.48 232251.0
Aug 25, 2026 45.48 47.46 45.14 46.75 373973.0
Aug 24, 2026 45.63 46.21 44.50 45.11 542006.0
Aug 21, 2026 45.74 46.49 45.00 45.89 322086.0
Aug 20, 2026 46.24 47.34 44.80 45.25 417413.0
Aug 19, 2026 44.02 47.25 44.00 46.96 515828.0
Aug 18, 2026 42.31 43.71 41.37 43.62 267317.0
Aug 17, 2026 42.90 43.26 42.08 42.45 502496.0
Aug 14, 2026 41.41 42.69 40.54 42.58 224044.0
Aug 13, 2026 42.52 42.60 40.32 40.79 265330.0
Aug 12, 2026 42.00 42.99 41.50 41.87 335546.0
Aug 11, 2026 41.37 42.04 40.95 42.02 208358.0
Aug 10, 2026 39.96 41.79 39.90 41.66 230343.0
Aug 07, 2026 39.55 41.13 39.51 40.17 315510.0

Price Definition

The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).

Read full definition.

Price Range, Past 5 Years

View Price Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Benchmarks

View Price Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. 4.08
Cytokinetics, Inc. 73.77
Perspective Therapeutics, Inc. 2.81
Capricor Therapeutics, Inc. 8.37
ACADIA Pharmaceuticals, Inc. 27.83

Price Related Metrics

PE Ratio 2.894
PS Ratio 3.337
PEG Ratio 0.0144
Price to Book Value 2.071
Price to Free Cash Flow 102.15
Earnings Yield 34.55%
Market Cap 881.21M
PEGY Ratio 0.0144
Operating PE Ratio 10.61
Normalized PE Ratio 2.893